BiomedicalPublications

OncoImmunology

Landes Bioscience·United States·ISSN 2162-4011

Open accessIn DOAJFee waivers availableImmunology and Microbiology

OncoImmunology is published by Landes Bioscience as an open access journal (ISSN 2162-4011). The list article processing charge is $2,913. Typical time to publication is 24 wks. Its OpenAlex h-index is 153. Primary field: Immunology and Microbiology. It is listed in the Directory of Open Access Journals. Fee waivers are stated as available. Figures on this page are sourced from OpenAlex and DOAJ and should be confirmed on the journal’s own site before submission.

Cost to publish

$2,913

Open-access article processing charge, list price.

Checked · Journal fee page

Time to publication

24 wks

Slower than average; plan your timeline accordingly.

h-index

153

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

6.1

Average citations to articles from the previous two years.

What it costs to publish here

Publishing an open-access article in OncoImmunology is listed at $2,913. The publisher also lists 2,375 GBP. The journal reports that fee waivers are available — worth pursuing if you are funding this yourself or working from a lower-income country.

The journal's own fee page →

Peer review and licensing

Review modelAnonymous peer review (policy)
LicenceCC BY, CC BY-NC
Author keeps copyrightNo
Plagiarism screeningYes
Editorial boardPublished →
LanguagesEN

Verification checks

8 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

  • Listed in the Directory of Open Access JournalsDOAJ applies a documented set of inclusion criteria.
  • Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.
  • Peer review model publicly declaredAnonymous peer review
  • Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.
  • Screens submissions for plagiarismReported to DOAJ by the journal.
  • Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.
  • Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.
  • Still actively publishingMost recent indexed article: 2026.

Scope

The subjects OncoImmunology publishes most, derived from the topics assigned to its indexed articles.

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesImmune Cell Function and InteractionCAR-T cell therapy researchImmune cells in cancerT-cell and B-cell ImmunologyVirus-based gene therapy researchMonoclonal and Polyclonal Antibodies ResearchImmune Response and InflammationPhagocytosis and Immune Regulation

Publication record

Indexed articles3,905
Total citations164,329
i10-index3,005
Most recent indexed article2026
Open access since2020
All ISSNs2162-4011, 2162-402X

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.